ID :
174784
Tue, 04/12/2011 - 09:23
Auther :

GCC Countries & Yemen Import 90 % Of Their Pharmaceutical Needs

Doha, April 11 (QNA) - The Secretary General of the Doha-based Gulf Organisation for industrial consulting (GOIC) Abdulaziz Bin Hamad Al-Aqeel has warned the GCC member states and Yemen against their continuing importing their Pharmaceutical Needs from abroad since these countries are currently importing about 90% of such needs despite the great growth of the market valume.
In his opening address of the GOIC-organised First Coordination Meeting for the Pharmaceutical Industry in the GCC & Yemen held at the Sheraton Doha Hotel here on Monday under the patronage of the Supreme council of Health (SCH), bin hamad al aqeel said the local Pharmaceutical Industry in the GCC & Yemen represents only a tiny percentage of the local market needs.
The pharmaceutical market in GCC countries & Yemen exceeds 6 billion USD. This market is growing rapidly and is expected to reach around 10 billion USD by 2020. Despite the growth of this market, local manufacturing is not able to meet the growing demand, and GCC countries continue to import most of their needs in medicines from abroad, he added.
Therefore, significant opportunities exist for growth and expansion of this sector in GCC. Expanding growth in this industry would also help to achieve the strategic objectives of the region in terms of industrial diversification into knowledge based industries, the GOIC secretary general noted.
As a part of its mandate to promote technical and policy coordination, GOIC has been organizing specialized coordination meetings for concerned bodies in the member states on regular basis. The proposed coordination meeting is the first of its kind in the sector and it could serve as a catalyst to promote further coordination at the horizontal and vertical levels.
The aforesaid meeting , the first ever of its kind in that sector, is aimed at achieving several objectives including to create a forum for the exchange of ideas and dialogue among pharmaceutical companies in GCC & Yemen, propose a multi-client study that will address the needs of the pharmaceutical industry in the region, and identify the need for establishing a pharmaceutical trade association for GCC producers.
In a similar address, the Assistant Secretary General for Policy Affairs at the SCH Dr. Faleh Mohamed Hussein has lauded the great significance the government of the State of Qatar accords to the Pharmaceutical Industry and medical utensils especially the launching last week by HH Sheikha Moza Bin Nasser the Deputy Chairperson of the SCH and the Executive Chairperson of the said committee of the six-year long overall national strategy for health starting this year and includes 35 projects.
The launching of Qatar National Vision 2030 since 2008 and the preparations that followed the launching of the first national development strategy 2011-2016 has really pushed forward the national strategy for health for the same years and which ia regarded one of other 14 reform sector strategies the national development strategy has involved, he added.
Elaborating Dr. Faleh Mohamed Hussein said that such an initiative has come to reflect the first step of gthe qatar national vision in which the health strategy is based on building strong partnership between the government ,the private sector and the civil society noting however that the launching of the health strategy in Qatar reaffirms Qatar's commitment to endorse a roadmap plan to materialize the seven targets set up by the SCH to respond to the society's health requirements .
He made clear that the SCH which has been set up to undertake the implementation of the Qatar National Vision 2030 goals, has already initiated to carry out a promising programme for improving the health services rendered for establishing a more healthy society for the present and the future.
Dr. Faleh Mohamed Hussein voiced hope the aforesaid meeting would act for providing a better future to the Pharmaceutical Industry in the region.
Despite the growth of this market, local manufacturing is not able to meet the growing demand, and GCC countries continue
to import most of their needs in medicines from abroad. Therefore, significant opportunities exist for growth and expansion of this
sector in GCC. Expanding growth in this industry would also help to achieve the strategic objectives of the region in terms of industrial diversification into knowledge based industries.
As a part of its mandate to promote technical and policy coordination, GOIC has been organizing specialized coordination meetings for concerned bodies in the member states on regular basis. The proposed coordination meeting is the first of its kind in the sector and it could serve as a catalyst to promote further coordination at the horizontal and vertical levels.
The objectives of the aforesaid meeting are to create a forum for the exchange of ideas and dialogue among pharmaceutical companies in GCC & Yemen, propose a multi-client study that will address the needs of the pharmaceutical industry in the region and identify the need for establishing a pharmaceutical trade association for GCC producers.
The meeting will include the following presentations and working papers namely the current and future trends of the pharmaceutical industry in the GCC," by GOIC, the pharmaceutical industry in global perspective, international expansion plans and potential opportunities in GCC States and Yemen," by a multinational pharmaceutical company , challenges for regional and global expansion," by a GCC pharmaceutical company and a proposal to create a trade association to represent the pharmaceutical
industry in the gulf," by GOIC.
The Gulf Organization for Industrial Consulting (GOIC) was founded in 1976 by the Arab Gulf States. Its mandate is to promote industrial cooperation and coordination among its six members, namely the Gulf Cooperation Council (GCC) States (UAE, Bahrain, Saudi Arabia, Oman, Qatar and Kuwait), and to foster industrial development both at the public and private sector levels.

X